Stereoselective high-performance liquid chromatographic determination of ketamine and its active metabolite, norketamine, in human plasma.
A stereoselective high-performance liquid chromatographic method for the determination of the enantiomers of ketamine and its active metabolite, norketamine, in human plasma is described. The compounds were extracted from plasma by liquid-liquid extraction three times in a combination of cyclohexane with 2.5 M NaOH, 1 mM HCl and 1 M carbonate buffer. Stereoselective separation was achieved on a Chiralcel OD column with a mobile phase of n-hexane-2-propanol (98:2, v/v). The detection wavelength was 215 nm. The lower limits of the determination of the method were 5 ng/ml for ketamine and 10 ng/ml for norketamine. The intra- and inter-day coefficients of variation ranged from 2.9 to 9.8% and from 3.4 to 10.7% for all compounds, respectively. The method was sensitive and sufficiently reproducible for stereoselective monitoring of ketamine and norketamine in human plasma during pharmacokinetic studies after the administration of ketamine for analgesia.
Yanagihara
Y
Y
Department of Hospital Pharmacy, Tokyo Posts and Telecommunications Hospital, Japan.
Ohtani
M
M
Kariya
S
S
Uchino
K
K
Aoyama
T
T
Yamamura
Y
Y
Iga
T
T
D000328:Adult; D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D007649:Ketamine / Q000031:analogs & derivatives* / Q000097:blood* / Q000737:chemistry; D008297:Male; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet; D013237:Stereoisomerism
D007649:Ketamine; C033419:norketamine